Alprazolam tablets, USP for oral administration are available as:
0.5 mg: Oval, peach tablets debossed GG 257 on one side and scored on the reverse side and supplied as:
NDC 66267-760-03 bottles of 3
NDC 66267-760-06 bottles of 6
Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].
Dispense in a tight, light-resistant container.
When rats were treated with alprazolam at 3, 10, and 30 mg/kg/day (15 to 150 times the maximum recommended human dose) orally for 2 years, a tendency for a dose related increase in the number of cataracts was observed in females and a tendency for a dose related increase in corneal vascularization was observed in males. These lesions did not appear until after 11 months of treatment.
Princeton, NJ 08540
| ALPRAZOLAM |
|Labeler — NuCare Pharmaceuticals, Inc. (010632300)|
|NuCare Pharmaceuticals, Inc.||010632300||repack (66267-760)|
Revised: 01/2021 NuCare Pharmaceuticals, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.